Current Drug Research Reviews
SJR0.487
AE
AEJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.487 | Q3 | 60.0% | |
| 2024 | — | — | 0.360 | Q3 | 51.5% | |
| 2023 | — | — | 0.400 | Q3 | 57.7% | |
| 2022 | — | — | 0.287 | Q3 | 49.3% | |
| 2021 | — | — | 0.288 | Q3 | 50.2% | |
| 2020 | — | — | 0.334 | Q3 | 53.8% | |
| 2019 | — | — | 0.806 | Q2 | 80.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2589-9775
ISSN
2589-9783
country
AEcoverage
2019-2026